Mercury Labs

9
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE947G01011
  • NSEID:
  • BSEID: 538964
INR
748.90
0.00 (0.00%)
BSENSE

Nov 20

BSE+NSE Vol: 19

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 1.11% vs -0.61% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 28.86% vs -22.30% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -0.53% vs 43.00% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 53.71% vs -44.38% in Mar 2025

Compare Profit and Loss Results of Mercury Labs
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
75.00
12.00
63.00
525.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
75.00
12.00
63.00
525.00%
Expenditure (Ex Depriciation)
Stock Adjustments
1.00
-3.00
4.00
133.33%
Raw Materials Consumed
27.00
13.00
14.00
107.69%
Power & Fuel Cost
1.00
1.00
0.00
0.00%
Employee Cost
17.00
2.00
15.00
750.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
0.00
5.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
3.00
0.00
3.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
66.00
15.00
51.00
340.00%
Operating Profit (PBDIT) excl Other Income
9.00
-3.00
12.00
400.00%
Other Income
1.00
0.00
1.00
0%
Operating Profit (PBDIT)
10.00
-3.00
13.00
433.33%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
10.00
-4.00
14.00
350.00%
Depreciation
3.00
1.00
2.00
200.00%
Profit Before Taxation & Exceptional Items
7.00
-5.00
12.00
240.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
-5.00
11.00
220.00%
Provision for Tax
1.00
-1.00
2.00
200.00%
Profit After Tax
4.00
-4.00
8.00
200.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
8.00
-6.00
14.00
233.33%
Profit Available for appropriations
13.00
-10.00
23.00
230.00%
Appropriations
13.00
-10.00
23.00
230.00%
Equity Dividend (%)
35%
0%
35.00
Earnings Per Share
40.28
-11
51.28
466.18%
Profit And Loss - Net Sales
Net Sales 75.94 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 1.11% vs -0.61% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.04 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 28.86% vs -22.30% in Mar 2025

Profit And Loss - Interest
Interest 0.54 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -0.53% vs 43.00% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 4.83 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 53.71% vs -44.38% in Mar 2025